Skip to main content
Equibles

IPCALAB · IPCA Laboratories Limited

Use IPCALAB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IPCALAB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,900.95 INR -37.45 (-1.93%) At close · Nov 12
Rebalance outlook locked
Volume · Nov 12 9634 Avg daily vol (3M) 40.73K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close1,900.95 INR Open1,941.40 INR Day1,882.40–1,943.95 INR 52W close1,302.70–2,011.00 INR Avg vol 30d29K Last earningsNov 5, 2026 DataJan 2022–Nov 2026

Raw chart and full-history price indicators begin at the captured split on Jan 10, 2022; bars on opposite sides are not compared.

Latest documents

2026
Nov 5
Earnings call
Consolidated EBITDA margin improved to around 22.97%

IPCA reported consolidated business growth of around 14% to around 2,910 crore. Management retained growth guidance of 14 to 16 percent and consolidated EBITDA margin guidance of 22 percent to 23 percent; Q2FI27 EBITDA margin improved to around 22.97%.

4 source passages
Mad September 2026, IPCA's rank remains 16, as per IQVIA. Our consolidated Q2FI26 business has grown by around 14% to around 2,910 crore, as against 2,557 crore. In earlier quarter, we have given guidance that overall growth guidelines was almost around 12 to 13 percent, which was revised to 14 to 16 percent. So that would remain. And consolidated EBITDA margin guidelines was from 22 percent to 23 percent. That will also stand here. overall consolidated EBITDA margins have improved to around 22.97% in Q2FI27 as against 21.68% in Q2FI26. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
▲9.4% 22.45B INR 2.48B INR '25 Q3 ▲10.5% 22.47B INR 678.20M INR '25 Q4 ▲10.3% 23.09B INR 2.33B INR '26 Q1 ▲8.6% 25.57B INR 2.83B INR '26 Q2 ▲6.6% 23.93B INR 3.26B INR '26 Q3 ▲6.3% 23.88B INR 2.99B INR '26 Q4 ▲20.8% 27.88B INR 4.02B INR '27 Q1 LATEST ▲13.8% 29.10B INR 3.75B INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 1,302.70 INR Now 1,900.95 INR · 84% Range high 2,011.00 INR
vs 200-day avg +12% vs 50-day avg -2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

Raw-price comparisons begin at the captured split on Jan 10, 2022; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
XBOM:IPCALAB -2.5% -0.7% +15.5% -1.4% +33.5%

Exchange listing

Market
XBOM
Ticker
IPCALAB
ISIN
INE571A01038
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.ipca.com/
Investor relations
https://www.ipca.com/investors-annual-reports

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2026-08-07 6.00 INR
2025-08-05 2.00 INR
2024-11-27 2.00 INR
2024-08-06 2.00 INR
2023-11-22 2.00 INR
2022-11-22 4.00 INR
2021-11-22 4.00 INR
2020-11-13 4.00 INR
2020-02-18 2.50 INR
2019-08-06 1.50 INR
2018-08-02 0.50 INR
2017-07-27 0.50 INR
2015-07-22 0.50 INR
2014-07-18 1.25 INR
2013-10-31 1.25 INR
2013-07-19 1.00 INR
2012-07-20 0.60 INR
2011-11-03 0.50 INR
2011-07-18 0.60 INR
2010-10-28 0.50 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-05 Audio Transcript
    Earnings Call
  • Earnings call · Q1 2027 2026-08-14 Audio Transcript
    Earnings Call
  • Earnings call · Q4 2026 2026-06-01 Transcript
    Earnings Call